文献速递儿童心血管与肾脏儿童消化与营养儿童血液肿瘤与免疫

儿童心脏、肝脏和肾脏移植的意向性治疗生存趋势

Trends in Survival for Pediatric Transplantation.
PubMed 文献 · Pediatrics · 2022-01-01

该研究对1987至2017年间列入心脏、肝脏和肾脏移植名单的儿童进行意向性治疗分析,发现三种器官移植的意向性治疗生存率均稳步改善,心脏移植1年内移植率显著增加,而肝脏和肾脏移植无显著增加。

要点

  • 儿童心脏、肝脏和肾脏移植的意向性治疗生存率从1987年至2017年稳步改善。
  • 心脏移植1年内移植率从60.8%增至68.7%,肝脏和肾脏移植无显著增加。
  • 等待名单生存率和移植后生存率在三种器官移植中均稳步改善。

核心结论

  • 意向性治疗生存率在1987至2017年间对心脏、肝脏和肾脏移植儿童均稳步改善。

研究设计与样本

  • 对12 984名心脏移植、17 519名肝脏移植和16 699名肾脏移植的列名儿童进行回顾性队列分析。
  • 使用Cox回归分析影响意向性治疗生存的因素,Kaplan-Meier法和log-rank检验评估生存变化。

主要发现

  • 意向性治疗生存率改善:心脏移植HR 0.96(95%CI 0.96-0.97),肝脏移植HR 0.95(95%CI 0.94-0.97),肾脏移植HR 0.97(95%CI 0.95-0.99)。
  • 等待名单生存率和移植后生存率在三种器官移植中均稳步改善。
  • 心脏移植1年内移植率从60.8%增至68.7%,肝脏移植从68.9%至72.5%无显著增加,肾脏移植从59.2%至62.7%无显著增加。

关键数值与推荐

  • 心脏移植意向性治疗生存HR 0.96(95%CI 0.96-0.97)。
  • 肝脏移植意向性治疗生存HR 0.95(95%CI 0.94-0.97)。
  • 肾脏移植意向性治疗生存HR 0.97(95%CI 0.95-0.99)。
  • 心脏移植1年内移植率60.8% vs 68.7%(1987 vs 2017)。
  • 肝脏移植1年内移植率68.9% vs 72.5%(无显著增加)。

临床怎么用

  • 意向性治疗生存分析可更全面地反映患者从列名到死亡的生存情况,有助于与家属沟通预后。
  • 继续扩大供体池、改善移植后结局和优化等待名单管理可能促进未来进步。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Progress in pediatric transplantation measured in the context of waitlist and posttransplant survival is well documented but falls short of providing a complete perspective for children and their families. An intent-to-treat analysis, in which we measure survival from listing to death regardless of whether a transplant is received, provides a more comprehensive perspective through which progress can be examined. METHODS: Univariable and multivariable Cox regression was used to analyze factors impacting intent-to-treat survival in 12 984 children listed for heart transplant, 17 519 children listed for liver transplant, and 16 699 children listed for kidney transplant. The Kaplan-Meier method and log-rank test were used to assess change in waitlist, posttransplant, and intent-to-treat survival. Wait times and transplant rates were compared by using χ2 tests. RESULTS: Intent-to-treat survival steadily improved from 1987 to 2017 in children listed for heart (hazard ratio [HR] 0.96, 95% confidence interval [CI] 0.96-0.97), liver (HR 0.95, 95% CI 0.94-0.97), and kidney (HR 0.97, 95% CI 0.95-0.99) transplant. Waitlist and posttransplant survival also improved steadily for all 3 organs. For heart transplant, the percentage of patients transplanted within 1 year significantly increased from 1987 to 2017 (60.8% vs 68.7%); however, no significant increase was observed in liver (68.9% vs 72.5%) or kidney (59.2% vs 62.7%) transplant. CONCLUSIONS: Intent-to-treat survival, which is more representative of the patient perspective than individual metrics alone, steadily improved for heart, liver, and kidney transplant over the study period. Further efforts to maximize the donor pool, improve posttransplant outcomes, and optimize patient care while on the waitlist may contribute to future progress.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Hickner B, Anand A, Godfrey EL, et al. Trends in Survival for Pediatric Transplantation. Pediatrics. 2022. PMID: 35079811. doi:10.1542/peds.2020-049632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。